Drug & medication recalls

Mycophenolate Mofetil recalled over manufacturing violations

Recall date
May 18, 2016
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Attix Pharmaceuticals Inc recalls Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or proc…
Recall number
D-1047-2016
FDA classification
Class III
Brand / firm
Attix Pharmaceuticals Inc
Sold / distributed
CO

Why it was recalled

cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada

Get recall alerts

Free email alert whenever Attix Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Attix Pharmaceuticals Inc